These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31415480)

  • 1. Development and Pilot Testing of MyGoutCare: A Novel Web-Based Platform to Educate Patients With Gout.
    Khanna P; Berrocal V; An L; Khanna D
    J Clin Rheumatol; 2020 Dec; 26(8):320-326. PubMed ID: 31415480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey.
    Singh JA; Edwards NL
    J Clin Rheumatol; 2020 Jun; 26(4):129-133. PubMed ID: 32453285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "What say ye gout experts?" a content analysis of questions about gout posted on the social news website Reddit.
    Derksen C; Serlachius A; Petrie KJ; Dalbeth N
    BMC Musculoskelet Disord; 2017 Nov; 18(1):488. PubMed ID: 29169350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive dietary education in treated gout patients does not further improve serum urate.
    Holland R; McGill NW
    Intern Med J; 2015 Feb; 45(2):189-94. PubMed ID: 25495503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout.
    Te Kampe R; Boonen A; Jansen TL; Elling JM; Flendrie M; van Eijk-Hustings Y; Janssen M; van Durme C; de Vries H
    BMC Med Inform Decis Mak; 2022 Apr; 22(1):95. PubMed ID: 35392890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of gout by clinicians in Nepal: a web-based survey.
    Vaidya B; Pudasaini K; Baral R; Nakarmi S
    Rheumatol Int; 2021 Jul; 41(7):1311-1319. PubMed ID: 33025111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional internet-based patient survey of the management strategies for gout.
    Singh JA; Shah N; Edwards NL
    BMC Complement Altern Med; 2016 Mar; 16():90. PubMed ID: 26931313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.
    Wood R; Fermer S; Ramachandran S; Baumgartner S; Morlock R
    J Rheumatol; 2016 Oct; 43(10):1897-1903. PubMed ID: 27036386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
    Bursill D; Dalbeth N
    Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of gout: Much has changed.
    Robinson PC; Stamp LK
    Aust Fam Physician; 2016 May; 45(5):299-302. PubMed ID: 27166465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on the beliefs and knowledge of gout management in new medical graduates - New South Wales, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2018 Feb; 21(2):517-522. PubMed ID: 28544467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout.
    Dalbeth N; Choi HK; Joosten LAB; Khanna PP; Matsuo H; Perez-Ruiz F; Stamp LK
    Nat Rev Dis Primers; 2019 Sep; 5(1):69. PubMed ID: 31558729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
    Zhang X; Tang Y; Wang M; Wang D; Li Q
    Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
    Latourte A; Bardin T; Clerson P; Ea HK; Flipo RM; Richette P
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):918-924. PubMed ID: 28834411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gout].
    Tausche AK
    Internist (Berl); 2021 May; 62(5):513-525. PubMed ID: 33721041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.